$33.40
+0.11 (+0.33%)
Open$33.31
Previous Close$33.29
Day High$33.68
Day Low$32.18
52W High$42.14
52W Low$7.45
Volume—
Avg Volume561.4K
Market Cap19.50M
P/E Ratio—
EPS$-142.73
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.90M | 5.57M |
| Net Income | -817,172 | -706,875 | -767,435 |
| Profit Margin | -13.6% | -12.0% | -13.8% |
| EBITDA | -1,135,758 | -954,399 | -978,652 |
| Free Cash Flow | -597,971 | -436,320 | -559,358 |
| Rev Growth | +2.3% | +18.9% | +16.5% |
| Debt/Equity | 0.18 | 0.16 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |